Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Pyng Medical has received special 510(K) regulatory clearance from the FDA to market its new and improved version of the FAST1 Intraosseous Infusion System throughout the US, effective immediately.
Subscribe to our email newsletter
FAST1 is said to be the most rapid, reliable and safe alternative to conventional IV infusion providing lifesaving vascular access for fluid and drug resuscitation in shock and trauma victims. The company’s lead clinical product has been re-engineered with a superior infusion tube that no longer requires the use of a removal tool.
David Christie, president and CEO of Pyng Medical, said: “As part of our ongoing commitment to technology innovation we’ve achieved procedural efficiencies and further enhanced the ease-of-use for our market-leading FAST1 Intraosseous Infusion System.”